Dyadic to Participate at Two Industry Events in May
May 10, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
April 26, 2023 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Biologics Market Worth USD 718.97 Billion to 2031 with 7.50% CAGR | Reveals Latest InsightAce Study
April 17, 2023 10:37 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Biologics Market is estimated to reach over USD 718.97 billion by 2031, exhibiting a CAGR of 7.50% during the forecast period. A...
Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers
April 04, 2023 08:05 ET
|
Avid Bioservices, Inc
Company to Host Open House to Celebrate Official Launch of Newest CGMP Mammalian Cell Manufacturing Suites within Myford Facility First Customer Project in Newly Expanded Capacity to Kick-Off This...
Global Bioprocess Validation Market is anticipated to cross US$ 449.03 Million by 2033 end at an aggressive CAGR of 9.20% | Deep analysis by Future Market Insights, Inc.
March 31, 2023 09:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 31, 2023 (GLOBE NEWSWIRE) -- As per the current market research conducted by FMI, the global Bioprocess Validation Market is expected to record a CAGR of 9.20% from 2023 to 2033....
Dyadic Reports 2022 Year End Results and Recent Company Progress
March 29, 2023 16:00 ET
|
Dyadic International, Inc.
Received regulatory approval for the ongoing First-In-Human Phase 1 trial to demonstrate clinical safety and antibody response in humans for DYAI-100 COVID-19 recombinant protein receptor binding...
Biologics Market Size Worth USD 710.53 Billion by 2030 at 7.6% CAGR – Report by Market Research Future (MRFR)
March 22, 2023 09:45 ET
|
Market Research Future
New York, USA, March 22, 2023 (GLOBE NEWSWIRE) -- Biologics Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Biologics Market Information By Product,...
Culture Biosciences Focuses Technology and Service Platform on Biologics
March 14, 2023 08:00 ET
|
Culture Biosciences
San Francisco, March 14, 2023 (GLOBE NEWSWIRE) -- SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) – Culture Biosciences today announced that it is increasing its focus on upstream bioprocess...
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments
March 13, 2023 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $38.0 Million, a 21% Increase Compared to Prior Year Quarter -- -- Signed $67 Million in Net New Business Orders Resulting in a Backlog of $176 million, an...
Berkshire Sterile to present on how to manage sensitive drug products, such as biologics and oligonucleotides
March 07, 2023 11:00 ET
|
Berkshire Sterile Manufacturing
Lee, MA, March 07, 2023 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM), a Massachusetts contract development and sterile manufacturing company, will describe how sensitive drug products...